Skip to main content

PYC looks to build $200m coffers

17/02/2025 - 10:47

Bookmark

Save articles for future reference.

Nedlands-based biotech company PYC Therapeutics is rattling the tin for up to $146 million to fund the progression of four novel drug candidates.

X

To read our articles you will need to either login or subscribe.